-
LTRN Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
Lantern Pharma (LTRN)
Company Profile
Quarter (USD) | Sep 24 | Jun 24 | Mar 24 | Dec 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 8.10 mm | 8.10 mm | 8.10 mm | 8.10 mm | 8.10 mm | 8.10 mm |
Cash burn (monthly) | 1.62 mm | 1.46 mm | 1.73 mm | 1.77 mm | 1.86 mm | 1.44 mm |
Cash used (since last report) | 8.23 mm | 7.37 mm | 8.74 mm | 8.94 mm | 9.42 mm | 7.27 mm |
Cash remaining | -123.22 k | 731.69 k | -639.41 k | -841.58 k | -1.32 mm | 833.87 k |
Runway (months of cash) | -0.1 | 0.5 | -0.4 | -0.5 | -0.7 | 0.6 |
13F holders | Current |
---|---|
Total holders | 35 |
Opened positions | 16 |
Closed positions | 5 |
Increased positions | 4 |
Reduced positions | 7 |
13F shares | Current |
---|---|
Total value | 8.02 bn |
Total shares | 4.92 mm |
Total puts | 600.00 |
Total calls | 4.60 k |
Total put/call ratio | 0.1 |
Largest owners | Shares | Value |
---|---|---|
Bios Equity Partners | 1.26 mm | $6.45 mm |
BIOS Capital Management | 1.21 mm | $3.85 bn |
PRPH ProPhase Labs | 631.20 k | $2.58 mm |
Green Park & Golf Ventures | 525.26 k | $10.11 mm |
Vanguard | 363.72 k | $1.16 bn |
CM Management | 200.00 k | $638.00 mm |
Renaissance Technologies | 87.30 k | $278.49 mm |
Geode Capital Management | 86.97 k | $277.52 mm |
GWM Advisors | 68.36 k | $218.07 mm |
Voss Capital | 50.00 k | $159.50 mm |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
24 Jul 24 | Keyser D Jeffrey | Common stock | Acquire X | No | No | 3.13 | 3,832 | 11.99 k | 0 | |
24 Jul 24 | Keyser D Jeffrey | Series A Warrants Common Stock | Dispose X | No | No | 3.13 | 3,832 | 11.99 k | 0 | |
15 Jul 24 | Sharma Panna | Stock Option Common Stock | Grant | Acquire A | No | No | 4.35 | 70,000 | 304.50 k | 70,000 |
15 Jul 24 | Maccecchini Maria-Luisa | Stock Option Common Stock | Grant | Acquire A | No | No | 4.35 | 5,000 | 21.75 k | 5,000 |
15 Jul 24 | Keyser D Jeffrey | Stock Option Common Stock | Grant | Acquire A | No | No | 4.35 | 5,000 | 21.75 k | 5,000 |
15 Jul 24 | David R. Margrave | Stock Option Common Stock | Grant | Acquire A | No | No | 4.35 | 52,000 | 226.20 k | 52,000 |